MOLECULES TO MEDICINE

Live / Allowed — Second extension granted (statement of use) (as of 12 May 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Oct 2020 filing date already counts against anyone who files later.

Record

Serial number
90259175
Mark type
Word mark
Filed
16 Oct 2020
Published for opposition
25 Mar 2025
Attorney of record
Robert V. Donahoe

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations featuring novel molecules for use in the treatment of hematological, oncological, rare, and chronic diseases and conditions for pre-marketing approval stage pre-clinical and clinical stage activities
  • Class 010 — Medical apparatus: Medical devices, namely, self-placeable electro stimulus intra-nasal devices intended to treat empty nose syndrome

Owner

Prosecution history

  • 13 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 12 May 2026 — SOU EXTENSION 2 GRANTED
  • 11 May 2026 — SOU EXTENSION 2 FILED
  • 12 May 2026 — SOU TEAS EXTENSION RECEIVED
  • 09 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 08 May 2026 — CORRECTED NOA E-MAILED
  • 08 May 2026 — SOU EXTENSION 1 GRANTED
  • 18 Nov 2025 — SOU EXTENSION 1 FILED
  • 08 May 2026 — DIVISIONAL PROCESSING COMPLETE
  • 19 Nov 2025 — DIVISIONAL REQUEST RECEIVED
  • 06 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 21 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 19 Nov 2025 — TEAS REQUEST TO DIVIDE RECEIVED
  • 19 Nov 2025 — SOU TEAS EXTENSION RECEIVED
  • 20 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT

View this trademark record on Rightsy